Frisch, Austin, et al. “Cyclophosphamide for the Treatment of Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome Following CD19-Targeted CAR T-Cell Therapy”. Journal of Medical Cases, vol. 17, no. 1, Jan. 2026, pp. 28-31, https://doi.org/10.14740/jmc5211.